Skip To Main Content
van’t Veer on Muck Rack

van’t Veer

As seen in: PNAS, The New England Journal of Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to van’t Veer’s profile

Articles by van’t Veer

Experimental analyses of temperature and pressure oscillation frequencies of a flat plate pulsating heat pipe tested under various edge orientation angles and heat loads | Experimental and Computational Multiphase Flow

|
By van’t Veer, Carrières sous Poissy
| link.springer.com
Abstract A closed loop flat plate pulsating heat pipe, filled with Opteon™ SF33 (with a filling ratio of 50%), was experimentally studied in different orientations: 0° (horizontal), 22.5°, 45°, 67.5°, and 90° (“;edge”: vertical with horizontal channels).
Open in Who Shared Issue with article?

ENPP1 is an innate immune checkpoint of the anticancer cGAMP–STING pathway in breast cancer | Proceedings of the National Academy of Sciences

|
By Alby J. Joseph, van’t Veer, Elika Bergelson, Melanie Soderstrom
| PNAS Verified
ENPP1 is an innate immune checkpoint of the anticancer cGAMP–STING pathway in breast cancer Songnan Wang https://orcid.org/0000-0002-4276-2965, Volker Böhnert, Alby J. Joseph https://orcid.org/0009-0001-6596-1078, +10 , Valentino Sudaryo https://orcid.org/0000-0002-5816-9955, Gemini Skariah, Jason T. Swinderman, Feiqiao B. Yu https://orcid.org/0000-0003-3416-3046, Vishvak Subramanyam https://orcid.org/0000-0002-6144-8322, Denise M. Wolf, Xuchao Lyu https://orcid.org/0000-0003-1967-3902, Luke A.
Open in Who Shared Issue with article?

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

|
By van’t Veer
| The New England Journal of Medicine Verified
The 70-gene signature test (MammaPrint) has been shown to improve prediction of clinical outcome in women with early-stage breast cancer. We sought to provide prospective evidence of the clinical utility of the addition of the 70-gene signature to standard clinical–pathological criteria in selecting patients for adjuvant chemotherapy.
Open in Who Shared Issue with article?
Show More